DORZOLAMIDE HYDROCHLORIDE (Sandoz Inc.)
Welcome to the PulseAid listing for the DORZOLAMIDE HYDROCHLORIDE drug offered from Sandoz Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | dorzolamide hydrochloride |
SUBSTANCE NAME: | DORZOLAMIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-06-01 |
END MARKETING DATE: | 0000-00-00 |
DORZOLAMIDE HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | DORZOLAMIDE HYDROCHLORIDE from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2009-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-019_5c7744eb-890b-3e4c-385c-33b142bbe815 |
PRODUCT NDC: | 61314-019 |
APPLICATION NUMBER: | ANDA078981 |
Other DORZOLAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: